TRL-10001

N/A

Report date: 2025/01/26 15:39:54

Base Information

Drug NameTRL-10001

Drug Alias Nameanti-ALK mAb (Trellis Bioscience)TRL-10001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionAnaplastic lymphoma kinase inhibitors

TargetsAnaplastic lymphoma kinase

Therapy Area/IndicationsNeuroblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTrellis Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesTrellis Bioscience Inc

Inactive CompaniesN/A

Active IndicationsNeuroblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A